Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults. - Wikidata - awgldk - TriplyDB

Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.

Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.

http://www.wikidata.org/entity/Q37598636

about

Adjunctive therapies for AIDS dementia complex Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir.Valproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individuals Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study.Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals Evaluation of different antiretroviral drug protocols on naturally infected feline immunodeficiency virus (FIV) cats in the late phase of the asymptomatic stage of infection.Safety of lopinavir/ritonavir for the treatment of HIV-infection.Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the Internati Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors.Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavir.The ART of HIV therapies: dopaminergic deficits and future treatments for HIV pediatric encephalopathy Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium Safe Treatment of Seizures in the Setting of HIV/AIDS.Induction effects of ritonavir: implications for drug interactions.Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor.Prevalence of seizures in children infected with human immunodeficiency virus.Possible interaction between lopinavir/ritonavir and valproic Acid exacerbates bipolar disorder.Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid.

P2860

Q24242140-8177A808-DC0C-48B0-A042-D77480E19018 Q27010594-296B2797-5DAA-480D-A5BC-AE35A228D1B2 Q34633457-56DE3A8C-E88D-4525-91D3-8453B2AEED2D Q34652709-DE1DA02D-D6B5-4CEE-8527-7E190A80E112 Q35057326-CF260644-0EFA-4FF9-8565-13B08A0FB806 Q35131181-6C420D32-3D7E-47C0-9406-EFF5FC343063 Q36096402-6A6396B9-C06E-4341-A67F-5BFDB57F309B Q36150530-F44D0C04-845B-4B6D-8592-7F393E7D380D Q36304546-EDAD51C5-4622-498B-BB4F-28A6A57DACFC Q36544977-C33FBB2B-9CF8-4F71-8A0F-56EA67973B3E Q36870884-B94466E4-1777-4D91-8B42-6127C60E16AE Q36991469-824C4E3A-BC59-4729-938E-DD3A8500C5BA Q37052151-763D17CF-0305-44C2-AE94-891F53B08171 Q37096562-14887E1E-50F0-4A69-B497-C85729010F74 Q37199533-4253EEFC-CC4F-4D1E-AB9D-F1F8B515B9AB Q37973439-63155A2A-3325-4FF5-8BD6-A47EA613B860 Q38513275-19EB5A34-7E99-4BE2-94D8-D2D2BBCF96D0 Q39872168-966959B4-7514-4918-B019-49C57B30FFB4 Q45356453-1D1B02C6-8B8F-4184-ABF6-A7D56970AA5D Q46861992-5E27526E-F83B-4840-8FA9-635F10F578B4 Q46895816-637AEC6D-2B18-474E-BFE8-25D58992F6E0 Q49825261-3901F91F-653C-4A8D-B8B8-F7841912ACC8

P2860

Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.

http://www.wikidata.org/entity/Q37598636

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Effects of valproic acid coadm ...... iciency virus-infected adults.

@en

Effects of valproic acid coadm ...... iciency virus-infected adults.

@nl

type

label

Effects of valproic acid coadm ...... iciency virus-infected adults.

@en

Effects of valproic acid coadm ...... iciency virus-infected adults.

@nl

prefLabel

Effects of valproic acid coadm ...... iciency virus-infected adults.

@en

Effects of valproic acid coadm ...... iciency virus-infected adults.

@nl

P1433

Q37598636-BC1275A7-08ED-48C2-9A11-672496FAB672

P1476

Q37598636-0453725F-0A11-42EC-B8EC-99C34B07BC7B

P2093

Q37598636-45225E07-DE6E-4B1F-923F-70EFA5991080

Q37598636-4EB45A96-04A3-40B6-9B6C-23F00AB52295

Q37598636-5DEBD02C-64C6-4B75-82B5-B06CC7B41417

Q37598636-5E6968DC-496E-426A-A3C7-A22B412755FD

Q37598636-66DE6CD6-F48B-442A-848E-80ACD07E3A8C

Q37598636-F351C4ED-022D-4FA0-BA53-97DF84AF245A

P2860

Q37598636-0BF5010A-2EC4-427E-955B-908FD0127E32

Q37598636-2492963A-1F4C-42A3-9633-6DA8C0005283

Q37598636-2890B9BF-8604-4A97-9546-64DA3F361FA6

Q37598636-2C825B8A-9E9E-4281-B6F2-461D7F82EE5F

Q37598636-3C065D5F-D786-4CAD-87D9-B5490C44F11A

Q37598636-45BB0E36-928F-4907-B368-0948D8915AEF

Q37598636-4D5DE862-04E2-496A-BB17-A24CC9BA483F

Q37598636-58D848BB-E7B1-44CD-9A48-F579E2932020

Q37598636-6392B2D2-41EC-424C-B28E-BE7042474781

Q37598636-6FFADFA0-1409-4594-BDF9-755D2C4C751B

P304

Q37598636-00FCD9C4-0EC8-4AA3-821B-D24ECF3D2CB1

P31

Q37598636-0143D31D-E032-47EA-AE34-DF262752952C

P356

Q37598636-3CDEEC3D-14FF-462A-A591-DE8ABAC9D971

P407

Q37598636-0384C456-8EFF-4F5D-B183-82591BDAEB74

P433

Q37598636-FCB5F151-327A-42F2-9B9E-832BB1982FDA

P478

Q37598636-36A8F3C5-49C1-4DA9-8ECC-9DBAD244758B

P50

Q37598636-796A2F8F-BEB9-4F7D-96B5-E97450969CD1

P577

Q37598636-4CEFE3EE-D8A9-4638-B3C8-9EE9D6435CEC

P698

Q37598636-58F1D86F-7C83-4803-B89A-EC61A2FDA185

P932

Q37598636-E9EF48CD-3975-4A76-989F-CA684F64CAB7

P356

AAC.48.11.4328-4331.2004

P1433

Antimicrobial Agents and Chemotherapy

P1476

Effects of valproic acid coadm ...... ficiency virus-infected adults

@en

P2093

Derick Peterson

http://www.w3.org/2001/XMLSchema#string

Garret Riggs

http://www.w3.org/2001/XMLSchema#string

Gene Morse

http://www.w3.org/2001/XMLSchema#string

Giovanni Schifitto

http://www.w3.org/2001/XMLSchema#string

Kim Cruttenden

http://www.w3.org/2001/XMLSchema#string

Robert DiCenzo

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism

Neuronal apoptosis in HIV infection in adults

Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity

HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity

Regulation of neuronal survival by the serine-threonine protein kinase Akt

Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.

Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors.

Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons.

A mechanistic approach to antiepileptic drug interactions.

P304

4328-4331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.48.11.4328-4331.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Harris A Gelbard

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15504860

http://www.w3.org/2001/XMLSchema#string

P932

525398

http://www.w3.org/2001/XMLSchema#string